Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors.
Haematologica
; 98(7): e78-9, 2013 Jul.
Article
in En
| MEDLINE
| ID: mdl-23753022
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Protein-Tyrosine Kinases
/
Leukemia, Myeloid, Accelerated Phase
/
Drug Resistance, Neoplasm
/
Protein Kinase Inhibitors
/
Harringtonines
/
Antineoplastic Agents, Phytogenic
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Haematologica
Year:
2013
Document type:
Article